HANWAYS CHEMPHARM CO.,LIMITED

Tacrolimus, UDCA, Paclitaxel, Docetaxel, Cabazitaxel Intermediates, Urokinase, Aprotinin, Fluorometholone, Mifepristone, Finasteride, Fulvestrant, Carboplatin, Oxaliplatin, Cisplatin,Nicotinic acid,Simethicone,Titanium Dioxide,Glycerol,Lactose Monohydrate,Sodium Chloride,Pyrodixine HCL,Thiamine HCL,CLARITHROMYCIN,FOLIC ACID,Ursodeoxycholic acid,Diclofenac Sodium,FUSIDIC ACID,Ciprofloxacin Hcl,Levofloxacin hemihydrate

HANWAYS CHEMPHARM CO.,LIMITED

Country: China (Mainland)Business Type: Trading Company

Premium supplierDiamond
supplier

qq

Contact US
Ms.Mandy
Tel: +86-18502787239(whatsapp)
Ms.Daisy
Tel: +86-18062643498
Ms.Cherry
Tel: 18064041549
Ms.Nancy
Tel: 13349969569
Ms.Hellen
Tel: 13349977857
Ms.April Hong
Tel: 18062049448
  • Fax: +86-27-83912198
  • URL: http://www.hanwayschem.com
  • Province/state: Hubei
  • City: Wuhan
  • Street:18-1-802, Green Garden, Jianghan District, Wuhan 430023, China
  • MaxCard:
Home > Products > 

Milrinone CAS:78415-72-2

Milrinone CAS:78415-72-2 CAS NO.78415-72-2

  • FOB Price: USD: 1.00-1.00 /Kilogram Get Latest Price
  • Min.Order: 1 Kilogram
  • Payment Terms: L/C,D/A,D/P,T/T,Other
  • Available Specifications:

    in-house(25-1000)Kilogram

  • Product Details

Keywords

  • Milrinone Manufacturer
  • 78415-72-2
  • Milrinone producer

Quick Details

  • ProName: Milrinone CAS:78415-72-2
  • CasNo: 78415-72-2
  • Molecular Formula: C12H9N3O
  • Appearance: almost white powder
  • Application: increase the heart's contractility and...
  • DeliveryTime: prompt shipment
  • PackAge: 25KG/DRUM
  • Port: Any China port
  • ProductionCapacity: 120 Metric Ton/Year
  • Purity: 99%
  • Storage: Preserve in tight, light-resistant con...
  • Transportation: General cargo transport
  • LimitNum: 1 Kilogram

Superiority

We are concentrating on APIs and pharmaceutical intermediates.

With in depth knowledge and understanding in this industry, we are indulged in supplying a wide assortments of Milrinone from Wuhan, Hubei, China.

It is made obtainable from us at the most reasonable rate.

Details

Year Establishment: 2009

Location: 18-1-802, Green Garden, Jianghan District, Wuhan 430023, China

Main product:
- API:Antiobesity; Oncology; Antiviral; Cardiovascular; Antibiotics; Antidiabetics and others
- Peptides
- Hormones
- Intermediates

 

Feature:

Product name

Milrinone

Synonyms

3-CYANO-6-METHYL-5-(4-PYRIDYL)-2-PYRIDONE; 6-METHYL-5-(4-PYRIDYL)-2-PYRIDONE-3-CARBONITRILE; 1,6-DIHYDRO-2-METHYL-6-OXO-(3,4'-BIPYRIDINE)-5-CARBONITRILE; 1,6-DIHYDRO-2-METHYL-6-OXO-3,4-BIPYRIDINE-5-CARBONITRILe; 1,2-DIHYDRO-6-METHYL-2-OXO-5-(4-PYRIDINYL)-NICOTINONITRILE

MOQ

25KG

CAS No.

78415-72-2

Appearance

  An almost white powder

Molecular Formula

C12H9N3O

Molecular Weight

211.22

Assay

99%

Application

Pharma grade or research purpose

Packing

As per your request

Storage

Preserve in tight, light-resistant containers in a cool place

Remarks

NA

Custom synthesis

Available

Supply Ability

10000kg/month

 

Medical use:

Milrinone is a medication used in patients who have heart failure. It is a phosphodiesterase 3 inhibitor that works to increase the heart's contractility and decrease pulmonary vascular resistance. Milrinone also works to vasodilate which helps alleviate increased pressures (afterload) on the heart, thus improving its pumping action. While it has been used in people with heart failure for many years, studies suggest that milrinone may exhibit some negative side effects that have caused some debate about its use clinically.

Overall, milrinone supports ventricular functioning of the heart by decreasing the degradation of cAMP and thus increasing phosphorylation levels of many components in the heart that contribute to contractility and heart rate. Milrinone use following cardiac surgery has been under some debate because of the potential increase risk of postoperative atrial arrhythmias. However, in the short term milrinone has been deemed beneficial to those experiencing heart failure and an effective therapy to maintain heart function following cardiac surgeries. There is no evidence of any long term beneficial effects on survival. In critically ill patients with evidence of cardiac dysfunction there is limited good quality evidence to recommend its use.

 

Package:

Other products of this supplier